Press Releases

 

March 03, 2018

Fyodor CEO to Speak at Harvard Africa Business Conference

Fyodor Chairman and CEO Dr Eddy Agbo will speak as a panelist on ‘Disruptive Innovation and the Future of Development in Africa’ at the 20th Harvard Africa Business Conference, March 2-4, 2018 in Boston MA. The panel discussion will be on March 03 from 3.30 PM US ET in Aldrich Hall, ROom 107. This year's conference under the theme “Values and Value Chains: Africa in a New Global Era” will bring together leaders who inspire others to make a difference in the world. The conference details can be seen at the Harvard Africa Business Conference website.


About Fyodor

Fyodor is a leading fever diagnostics biotech company delivering a portfolio of non-invasive products that address global health diseases in emerging markets. We create consumer-facing medical diagnostic products that empower patient-centric healthcare management to expand and democratize access to appropriate individualized care in home settings. Fyodor has commercialized the Urine Malaria Test (UMT) – the first and only non-blood dipstick test that tells within 25 minutes if a fever is malaria, using a few drops of urine, and works just like a pregnancy test. With the UMT, we are democratizing malaria testing, making it possible for anyone, anywhere, to promptly test, to save lives at scale.


Contact

Fyodor Biotechnologies

Ph: +1.443.300.6236

       +234.902.639.6367

fyodor@fyodorbio.com

www.fyodorbio.com

April 12, 2018

Fyodor CEO to Speak on ‘Frugal Innovations in Medicine’ at the 2018 MedTech Summit

Fyodor today announced that Chairman and CEO Dr Eddy Agbo will speak on ‘Frugal Innovations in Medicine’ at the 2018 MedTech Summit, Nuremberg, Germany, at 9.20 AM CET / 8.20 AM WAT / 3.20 AM US ET). The summit, to be held in partnership with MT-Connect under the auspices of the Bavarian Ministry of Economic Affairs is the premier global forum for medical device manufacturers, clinicians, scientists and suppliers in the medical technology space. The conference details are available at the MedTech Summit website.


About Fyodor

Fyodor is a leading fever diagnostics biotech company delivering a portfolio of non-invasive products that address global health diseases in emerging markets. We create consumer-facing medical diagnostic products that empower patient-centric healthcare management to expand and democratize access to appropriate individualized care in home settings. Fyodor has commercialized the Urine Malaria Test (UMT) – the first and only non-blood dipstick test that tells within 25 minutes if a fever is malaria, using a few drops of urine, and works just like a pregnancy test. With the UMT, we are democratizing malaria testing, making it possible for anyone, anywhere, to promptly test, to save lives at scale.

Contact

Fyodor Biotechnologies

Ph: +1.443.300.6236

       +234.902.639.6367

fyodor@fyodorbio.com

www.fyodorbio.com


1100 Wicomico Street, Ste 700

Baltimore, Maryland 21230, USA

+1.443.300.6236


12 Osho Street | Opebi Link Road

Ikeja | Lagos | NIGERIA

+234.902.6.FYODOR (396367)

+234.902.7.FYODOR (396367)

Email: FYODOR@fyodorbio.com


© 2019 | FYODOR BIOTECHNOLOGIES